SEZ6L2 was observed to be significantly upregulated in 29 tumors such as BRCA, CESC, LUAD, ESCA, STES, KIRP, KIPAN, COAD, COADREAD, PRAD, STAD, HNSC, KIRC, LUSC, LIHC, WT, SKCM, BLCA, THCA, READ, OV PAAD, TGCT, UCS, ALL, LAML, PCPG, ACC, and CHOL; we observed significant downregulation in two tumors such as GBM and KICH (Figure 9(b)). This evidence concerns the gene BCR and glioblastoma.